TROAP-AS1: A Potential Drug Target and Biomarker (G101927267)

Target Name: TROAP-AS1

NCBI ID: G101927267

TROAP-AS1

Other Name(s): TROAP and PRPH antisense RNA 1

TROAP-AS1: A Potential Drug Target and Biomarker

TROAP-AS1 (Troapidine-conjugated RNA-protein hybrid as 1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is derived from the protein TROAP (Troapin) and is composed of a unique RNA-protein hybrid. This hybrid has been shown to play a critical role in the regulation of cell growth, apoptosis, and translation.

The TROAP gene is located on chromosome 16 and encodes a protein that is expressed in a variety of tissues, including brain, heart, liver, and muscle. The protein has a molecular weight of approximately 28 kDa and is composed of 155 amino acid residues. It has a single transmembrane domain and a N-terminus that is fused to the cytoplasmic tail of the protein.

TROAP-AS1 has been shown to play a critical role in the regulation of cell growth and apoptosis. It has been shown to inhibit the activity of the oncogene transforming growth factor-?? (NF-kappa), which is a key regulator of cell growth and has been linked to a variety of diseases, including cancer.

In addition to its role in cell growth and apoptosis, TROAP-AS1 has also been shown to play a critical role in the regulation of translation. It has been shown to interact with the protein translation factor eIF4F and play a role in the loading of mRNAs onto the eIF4F complex. This interaction between TROAP-AS1 and eIF4F suggests that it may be a potential drug target for therapies that target translation.

TROAP-AS1 has also been shown to be involved in the regulation of inflammation. It has been shown to play a critical role in the regulation of the immune response and has been linked to the production of pro-inflammatory cytokines. This suggests that TROAP-AS1 may be a potential biomarker for the development of inflammatory diseases.

In conclusion, TROAP-AS1 is a non-coding RNA molecule that has been shown to play a critical role in the regulation of cell growth, apoptosis, translation, and inflammation. Its unique RNA-protein hybrid and its involvement in these critical processes make it a potential drug target and biomarker. Further research is needed to fully understand the role of TROAP-AS1 in these processes and to develop effective therapies that target it.

Protein Name: TROAP And PRPH Antisense RNA 1

The "TROAP-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TROAP-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets